Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Share of drug costs by type in public drug plans Canada 2011/12 to 2017/18

Patented drugs made up nearly 63 percent of all drug costs in select Canadian public drug plans in fiscal year 2017/2018, including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador and the Non-Insured Health Benefits Program.

Share of drug costs by type in select public drug plans in Canada from 2011/2012 to 2017/2018

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2019

Region

Canada

Survey time period

fiscal years 2011/2012 to 2017/2018

Supplementary notes

* Including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador and the Non-Insured Health Benefits Program.
The rest of percentages falls under 'other' (includes devices, compounded drugs, and other products that are reimbursed by public drug plans but do not have a Health Canada assigned Drug Identification Number (DIN)).

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.